Loading...
Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation
BACKGROUND: The Intergroup Exemestane Study (IES) (ISRCTN11883920) demonstrated improved survival for postmenopausal women with ER-positive/unknown primary breast cancer who switched to exemestane after 2–3 years tamoxifen, compared with those continuing on tamoxifen to complete 5 years therapy. Thi...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3304414/ https://ncbi.nlm.nih.gov/pubmed/22353807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.43 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|